Biochemical and Biophysical Research Communications
Volume 196, Issue 2, 29 October 1993, Pages 1010-1016
Regular ArticleAmplification and Overexpression of Cyclin D1 in Human Hepatocellular Carcinoma
References (0)
Cited by (232)
Multistage Carcinogenesis: Cell and Animal Models
2018, Comprehensive Toxicology: Third EditionWee1 kinase inhibitor AZD1775 radiosensitizes hepatocellular carcinoma regardless of TP53 mutational status through induction of replication stress
2016, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :TP53 is commonly mutated or underexpressed in several human HCC cell lines (32), suggesting that many liver tumors are dependent on the G2 checkpoint to repair DNA damage. Additionally, abnormal expression of cell cycle regulators is believed to be a major contributor to hepatocellular carcinogenesis and progression (33-38). This vulnerability of HCC may be effectively targeted with cell cycle checkpoint inhibitors.
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
2023, Cell Death and DiseaseMolecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities
2022, Frontiers in Pharmacology
Copyright © 1993 Academic Press. All rights reserved.